# A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study

Source: https://onco.cc/trials/nct07609251/  
OnCo record `nct07609251` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of SCTB41 and docetaxel in lung cancer, run by Sinocelltech Ltd., not yet recruiting.

## Summary

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing） is a phase 2, interventional study registered as NCT07609251 by Sinocelltech Ltd., with a registry enrolment figure of 90 participants, started 2026-05 and due to reach its primary completion in 2028-10. Interventions recorded: SCTB41; docetaxel. Conditions listed: NSCLC (Advanced Non-small Cell Lung Cancer). Primary outcome: Frequency of adverse events (AEs). Lung eligibility wording from the registry: "Histologically or cytologically confirmed locally advanced (Stage IIIB/IIIC) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) that is not amenable to complete surgical resection and cannot receive curative concurrent/sequential chemoradiotherapy;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07609251
- Phase: 2
- Setting: A Phase II/III Study of SCTB41 Plus Docetaxel vs Placebo Plus Docetaxel in Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Sponsor: Sinocelltech Ltd.
- Enrolled: 90

## Sources

- ClinicalTrials.gov NCT07609251: https://clinicaltrials.gov/study/NCT07609251

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Docetaxel](https://onco.cc/drugs/docetaxel/), [SCTB41](https://onco.cc/drugs/sctb41/)
- companies: [Sinocelltech](https://onco.cc/companies/sinocelltech/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07609251.json